NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Indian Equities Post Sharpest Correction in Recent Memory, Top PMS Strategies Shine

The Indian equity market faced a severe correction in March 2026, with the S&P BSE 500 TRI plummeting by nearly 11.4%. Amidst this downturn, a select group of top Equity Portfolio Management Scheme (PMS) strategies demonstrated remarkable resilience. These PMS strategies, ranked by one-month returns as of March end and sourced from PMS Bazaar, showcased a range of approaches, from disciplined quant models to high-conviction stock-picking and tactical macro bets.

Top 10 Portfolio Management Schemes for March 2026

RankPMS NameOne-Month Return (March 2026)
1Qode Advisors LLP - Qode Disciplined Quant (Small-Cap)-2.12%
2Qode Advisors LLP - Qode Tactical Fund (Multi Cap & Flexi Cap)-3.85%
3Qode Advisors LLP - Qode All Weather (Multi Cap & Flexi Cap)-4.21%
4Investvalue Capital - India Winners Portfolio (Multi Cap & Flexi Cap)-5.61%
5Envision Capital Services - Envision New Frontiers (Multi Cap & Flexi Cap)-6.32%
6Capital 8 LLP - Capital 8 Infinity Fund (Multi Cap & Flexi Cap)-7.12%
7Acepro Advisors - Galaxy Strategy (Multi Cap & Flexi Cap)-7.45%
8Maxiom Asset Management - DIAMOND (Multi Cap & Flexi Cap)-7.91%
9Wave Asset - Bloom (Multi Cap & Flexi Cap)-8.21%
10Valuequest Investment Advisors - Growth (Multi Cap & Flexi Cap)-8.51%

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

PMS Spotlight: Qode Advisors LLP

Qode Advisors LLP dominated the top three spots with its disciplined quant models. The firm's flagship quant small-cap play, O.N.E. (operational outperformance, normalized momentum, and earnings quality), helped the strategy punch above its weight in a brutal month for small-caps. Launched in March 2025, O.N.E. focuses on fundamentally strong, under-the-radar compounders early. The top holdings in this strategy include Karur Vysya Bank, Steelcast, Kwality Pharma, City Union Bank, and Welspun Corp, showcasing a clear tilt towards quality banks and niche industrials/pharma.

Other Notable PMS Strategies

  • Qode Advisors LLP's Qode Tactical Fund, a pure momentum-driven quant strategy, systematically rotated into the strongest trending segments via ETFs, limiting damage in March's sell-off.
  • Investvalue Capital's India Winners Portfolio, a research-led multi-cap strategy, drove high-conviction bets on structural India themes, including formalisation, consumption boom, manufacturing push, and digital shift.
  • Envision Capital Services' Envision New Frontiers, a growth-oriented strategy, followed a bottom-up focus on capital-efficient businesses that can scale in emerging India opportunities.
  • Capital 8 LLP's Capital 8 Infinity Fund followed a macro and market cycle analysis for early-sector identification and strict risk management.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Investor Takeaway

Investors should consider diversifying their portfolios with top-performing equity portfolio management schemes.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.